Pacific Biosciences Of California (PACB) Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California's Non-Current Assets history runs 17 years deep, the most recent figure standing at $412.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 0.73% year-over-year to $412.8 million; the TTM figure through Mar 2026 stood at $1.6 billion (down 43.89% YoY), while the FY2025 annual figure was $409.0 million, down 46.52% from the prior year.
• Non-Current Assets was $412.8 million for Q1 2026 at Pacific Biosciences Of California, up from $409.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.0 billion in Q3 2023 to a low of $408.9 million in Q3 2025.
• Historically, Non-Current Assets has averaged $767.3 million across 5 years, with a median of $905.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 1499.18% in 2022, then slumped 58.12% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $915.0 million in 2022, then increased by 9.72% to $1.0 billion in 2023, then slipped by 23.83% to $764.8 million in 2024, then sank by 46.52% to $409.0 million in 2025, then increased by 0.93% to $412.8 million in 2026.
• The last three Non-Current Assets figures came in at $412.8 million (Q1 2026), $409.0 million (Q4 2025), and $408.9 million (Q3 2025), per Business Quant data.